ghk cu and c60 GHK-Cu 400 mgVeganNon GMOLab TestedIn House VerifiedEnriched with copper peptides GHK-CU
Description
Proven alternatives deliver comparable results with established safety: tirzepatide monotherapy produces 15-22% weight loss with FDA approval and extensive clinical data, while CagriSema (cagrilintide + semaglutide) delivers 15-25% weight loss with Phase 3 trial validation and clearer path to medical acceptance
Keep in original sealed packaging until use
Because of our product nature, returns are not accepted
[Google Scholar] 13.Szabo S, Trier JS
